Real Labs, Actual Decisions With Actionable Six Sigma Metrics

QuidelOrtho Announces Featured ADLM Session

How can actionable, Six Sigma insights improve lab performance? In a featured session at the Association for Diagnostics & Laboratory Medicine (ADLM) meeting, QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”) and a panel of experts will share how QuidelOrtho's Six Sigma tools and real lab data can drive quality outcomes.

https://mma.prnewswire.com/media/2732815/QuidelOrtho_Corporation_Angela_Armato.jpg

ADLM Session Details:

Session Title: Real Labs, Real Decisions with Actionable Six Sigma MetricsWhen: Tuesday, July 29, 2025Where: McCormick Convention Center Chicago, IL Exhibit Hall, Theater 1Time: 2:45 p.m. – 3:45 p.m. CTRegistration: Space is limited. ADLM attendees can register for the session using this link: https://www2.na-ma.quidelortho.com/25-adlm-workshop-subscribe Media registered for ADLM – please reach out to Nikki Wheeler to access the session at Nikki.Wheeler@QuidelOrtho.com

Real Labs, Real Decisions With Actionable Six Sigma Metrics Panelists:

Dr. Jared Jaeger Clinical Science Liaison QuidelOrtho Moderator

Dr. Bremansu Osa-Andrews Medical Director of Clinical Chemistry and Clinical Assistant Professor University of Florida PathLab

Gilles Attipoe Director of Laboratory Services St. Peter's University Hospital

Angela Armato Core Lab Manager United Health Services and UHS Hospitals

To learn more about Six Sigma and the value of using real-world data listen to”Sigma Metrics and the Value of Real World Evidence.” In this podcast, QuidelOrtho data scientist Johanna Miller discusses how Six Sigma metrics are being adapted for the clinical laboratory.

Unable to attend ADLM? Register to watch a recording of the session: https://www2.na-ma.quidelortho.com/25-adlm-workshop-subscribe.

About QuidelOrtho QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.

Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed-from home to hospital, lab to clinic.

Building on its long history of innovation, QuidelOrtho works with global healthcare customers to advance diagnostics, where insights and solutions seamlessly connect, illuminating a clearer path for informed decisions.

Investor Contact: Media Contact:Juliet Cunningham D. Nikki WheelerVice President, Investor Relations Senior Director, Corporate CommunicationsIR@QuidelOrtho.com Media@QuidelOrtho.com

https://mma.prnewswire.com/media/2732817/QuidelOrtho_Corporation___Gilles_Attipoe.jpg

https://mma.prnewswire.com/media/2732816/QuidelOrtho_Corporation_Dr_Bremansu_Osa_Andrews.jpg

https://mma.prnewswire.com/media/2732820/QuidelOrtho_Corporation_Jared_Jaeger_PhD.jpg

https://mma.prnewswire.com/media/2724032/QuidelOrtho_Corporation_Logo.jpg

https://c212.net/c/img/favicon.png?sn=LA31975&sd=2025-07-17

View original content to download multimedia:https://www.prnewswire.com/news-releases/real-labs-actual-decisions-with-actionable-six-sigma-metrics-302507241.html

SOURCE QuidelOrtho Corporation

https://rt.newswire.ca/rt.gif?NewsItemId=LA31975&Transmission_Id=202507170700PR_NEWS_USPR_____LA31975&DateId=20250717